Insulin act of 2026

Insulin Act of 2026

Source of recordUS Congress · congress.govLast synced Aug 13, 2026

Chamber

Senate

Progress

Where this bill stands in the legislative process.

Introduced
Passed Senate
Passed House
To President
Became Law

Overview

The Insulin Act of 2026 aims to lower the cost of insulin for patients and provide protections for those struggling with its expenses. It mandates that health plans cover selected insulin products at cost, prohibits excessive cost-sharing, and requires pharmacies to pass through all rebates to the plans. The bill also seeks to increase competition in the insulin market and provide assistance to uninsured individuals seeking affordable insulin through a pilot program and a resource center.

Key provisions

Part D plans must cover at least one of each dosage form and type of insulin, with cost-sharing limits of $35 per 30-day supply.
Pharmacy benefit managers must pass through all rebates and fees related to insulin to health plans.
Health plans must not impose prior authorization requirements on selected insulin products, except for safety reasons.
A pilot program will provide affordable insulin to uninsured individuals in selected states.
The GAO will conduct a study on the characteristics of uninsured individuals who use insulin.
A resource center and hotline will be established to connect uninsured individuals with assistance programs.
The bill amends the Employee Retirement Income Security Act (ERISA) and the Internal Revenue Code to align insulin coverage requirements.
The bill expedites biosimilar competition for insulin products.

Who is affected

Bill text

Read the latest version inline or switch to a previous version.

Mar 25, 2026XMLView source

Text extraction is in progress. View the official source.

Legislative history

6 recorded actions

Mar 25, 2026Senate

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Mar 25, 2026

Introduced in Senate

Jul 22, 2026Senate

Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.

Aug 7, 2026Senate

Placed on Senate Legislative Calendar under General Orders. Calendar No. 552.

Aug 7, 2026Senate

Committee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute. Without written report.

Aug 7, 2026

Committee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute. Without written report.

Geography

Recorded positions across the country.

No public positions recorded for this legislation.

Arguments

Reasons offered for and against this legislation.

Arguments in favor

No arguments in favor have been submitted.

Submit yours

Arguments opposed

No arguments opposed have been submitted.

Submit yours

Insulin act of 2026

Progress